During the past decade, Fundacion Santa Fe de Bogota conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Santa Fe de Bogota" #1 sponsor was "Actelion" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Fundación Santa Fe de Bogota" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AO Innovation Translation Center" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Santa Fe de Bogota" #1 collaborator was "Clinica de La Mujer" with 1 trials as a collaborator, "Consejo Interamericano de Falla Cardíaca e Hipertensión Pulmonar (CIFACAH)" with 1 trials as a collaborator, "Fundación Santa Fe de Bogota" with 1 trials as a collaborator, "Haukeland University Hospital" with 1 trials as a collaborator and "Hospital Fernandez" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Santa Fe de Bogota" are "Chronic Myeloid Leukemia" (3 trials), "Covid-19" (2 trials), "Hip Fractures" (2 trials), "Multiple Myeloma" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Fundacion Santa Fe de Bogota" in a lesser frequency.

Most popular intervention types in "Fundacion Santa Fe de Bogota" are "Drug" (15 trials), "Other" (7 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bosutinib" (2 trials), "Standard care" (2 trials), "ADT (Standard of Care)" (1 trials) and "All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics." (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Santa Fe de Bogota" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fundacion Santa Fe de Bogota". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Fundacion Santa Fe de Bogota, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Santa Fe de Bogota, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".